Indoximod (NLG-8189, 1-Methyl-D-tryptophan) is used as an inhibitor of the IDO (indoleamine 2,3-dioxygenase) pathway to reverse IDO-mediated immunosuppression; it is under Phase 2 clinical investigation. It is also used in the preparation of natural products such as macroline alkaloids; in Pictet-Spengler reactions of tryptophan esters and aldehydes; and in the synthesis of 1-substituted indolactam precursors.